Analytic Investors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCA
CM
JWA
AIC
RFC
TCM
AR
MCM
MIP
Analytic Investors's IRMD Position: Q1 2016 in Review
Analytic Investors sold out of iRadimed (IRMD) in Q1 2016, closing a stake of 8,632 shares — an estimated $242K sold.
Analytic Investors first reported a position in IRMD in Q3 2015 and held it in 2 quarters. The position peaked at $505K in Q3 2015. 66 funds tracked by Wall St. Rank hold IRMD as of Q1 2016.
- Analytic Investors reported no remaining iRadimed position as of Q1 2016 after selling out during the quarter.
- Analytic Investors sold 8,632 iRadimed shares in Q1 2016, an estimated $242K.
- Analytic Investors first reported a position in iRadimed in Q3 2015 and held it in 2 quarters.
- Analytic Investors's iRadimed position peaked at $505K in Q3 2015.
- 66 funds tracked by Wall St. Rank held iRadimed as of Q1 2016.
Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.